Cisco has invested $6m in the Jordan-focussed Badia Impact Fund, in its first close including investments from the European Investment Bank and Jordan's King Abdullah Fund for Development.

Biotechnology company Thesan Pharmaceuticals raises $49m series B financing led by current investor Novo Ventures, and including Lundbeckfond Ventures and Novartis Venture Funds, to develop novel medicines for treating dermatological conditions such as acne.

Japan Asia Investment Corporation (JAIC) and Nippon Venture Capital Corp (NVCC) have led a $9.2m series D round of funding for Regimmune, a Japanese biotechnology company focused on the discovery, development and commercialisation of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, auto-immune diseases and transplantation.

Leeds spin-out Ionix Advanced Technologies secures investment from IP Group for unspecified sum.

Virginia biotech Neoantigenics announces early stage collaboration with Pfizer.

Antibody search engine Citeab spins out from the University of Bath.

Tangent Medical agrees $5m senior debt credit facility from GE Capital Healthcare Financial Services for Europe push.